We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$26.3B
AUM Growth
+$2.84B
Cap. Flow
+$1.22B
Cap. Flow %
4.63%
Top 10 Hldgs %
17.1%
Holding
3,009
New
172
Increased
1,653
Reduced
960
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 8.1%
2 Financials 6.17%
3 Healthcare 4.86%
4 Communication Services 3.82%
5 Consumer Discretionary 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
2826
DELISTED
Acorda Therapeutics
ACOR
$31K ﹤0.01%
130
+25
+24% +$6.31K
NAK
2827
Northern Dynasty Minerals
NAK
$885M
$30K ﹤0.01%
71,325
WPRT
2828
Westport Fuel Systems
WPRT
$36.5M
$30K ﹤0.01%
1,303
-12
-0.9% -$308
SJT
2829
San Juan Basin Royalty Trust
SJT
$117M
$29K ﹤0.01%
11,418
-3,354
-23% -$8.48K
ATHX
2830
DELISTED
Athersys, Inc. Common Stock
ATHX
$29K ﹤0.01%
972
HCR
2831
DELISTED
Hi-Crush Inc. Common Stock
HCR
$29K ﹤0.01%
33,949
+6,477
+24% +$6.83K
EMX
2832
DELISTED
EMX Royalty
EMX
$26K ﹤0.01%
16,019
RMTI icon
2833
Rockwell Medical
RMTI
$26.2M
$26K ﹤0.01%
100
-15
-13% -$3.77K
ADIL
2834
Adial Pharmaceuticals
ADIL
$6.08M
$25K ﹤0.01%
17
INOD icon
2835
Innodata
INOD
$1.83B
$25K ﹤0.01%
22,200
FTEK icon
2836
Fuel Tech
FTEK
$48M
$24K ﹤0.01%
25,865
PMTS icon
2837
CPI Card Group
PMTS
$224M
$23K ﹤0.01%
25,602
-1,881
-7% -$2.83K
TURN
2838
DELISTED
180 Degree Capital
TURN
$23K ﹤0.01%
3,686
PAVM icon
2839
PAVmed
PAVM
$33.9M
$20K ﹤0.01%
+38
New +$15.8K
NEOS
2840
DELISTED
Neos Therapeutics, Inc
NEOS
$20K ﹤0.01%
13,600
+2,000
+17% +$3K
NGD
2841
DELISTED
New Gold Inc
NGD
$19K ﹤0.01%
21,986
+9,337
+74% +$8.45K
ELGX
2842
DELISTED
Endologix Inc
ELGX
$19K ﹤0.01%
+12,550
New +$35.1K
SCYX icon
2843
SCYNEXIS
SCYX
$37M
$16K ﹤0.01%
229
-161
-41% -$13.3K
CATX icon
2844
Perspective Therapeutics
CATX
$332M
$15K ﹤0.01%
2,528
TMDI
2845
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$15K ﹤0.01%
30,485
-8,339
-21% -$5.12K
VGZ icon
2846
Vista Gold
VGZ
$253M
$14K ﹤0.01%
20,000
-180
-0.9% -$130
TTOO
2847
DELISTED
T2 Biosystems, Inc
TTOO
$13K ﹤0.01%
2
-1
-33% -$9.45K
CTST
2848
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$13K ﹤0.01%
14,427
-7,296
-34% -$7.26K
DMK
2849
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$12K ﹤0.01%
+250
New +$12.1K
NE
2850
DELISTED
Noble Corporation
NE
$12K ﹤0.01%
10,550
-5,059
-32% -$6.05K

Similar funds

Commonwealth Equity Services's Q4 2019 Portfolio in Review

As of Q4 2019, Commonwealth Equity Services held 3,009 positions worth $26.3B, up 12% from $23.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Commonwealth Equity Services deployed $1.22B of net new capital in Q4 2019, opening 172 new positions and adding to 1,653 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF December: 815,338 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 10-20 Year Treasury Bond ETF, an estimated $20.5M trimmed.

  • Commonwealth Equity Services's largest Q4 2019 buy was Innovator US Equity Power Buffer ETF December: 815,338 shares worth $21.8M.
  • Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $48.6M increase.
  • Commonwealth Equity Services's biggest Q4 2019 reduction was iShares 10-20 Year Treasury Bond ETF, cutting an estimated $20.5M.
  • Commonwealth Equity Services fully exited Celgene Corp in Q4 2019, selling an estimated $13.7M.
  • Commonwealth Equity Services's ten largest holdings make up 17% of its $26.3B portfolio in Q4 2019.
  • Commonwealth Equity Services opened 172 new positions and closed 126 in Q4 2019.
  • Commonwealth Equity Services's portfolio value rose 12% quarter-over-quarter to $26.3B.

Based on Commonwealth Equity Services's 13F filing for Q4 2019, filed 5 Feb 2020.